Jefferies Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$525K	Buy	+67,654	New	+$525K	﹤0.01%	642
2022 Q1	–	Sell	-78,308	Closed	-$774K	–	1195
2021 Q4	$774K	Buy	+78,308	New	+$774K	﹤0.01%	617